Philippe Camus, M.D.

Dijon, France

Back to drug

The Drug-Induced Respiratory Disease Website

XXIV.i

Progression, acceleration or exacerbation of preexisting ILD/fibrosis

(Fr: aggravation d'une Pn interstitielle préexistante). The preexistinf ILD can be idiopathic pulmonary fibrosis (IPF), rheumatoid lung, CTD-related or any kind of ILD/pulmonary fibrosis. Can cause acute fatal respiratory failure in 25-30% of those affected. See also Iw.

Publications

Ishioka Y, Makiguchi T, Itoga M, Tanaka H, Taima K, Goto S, Tasaka S

Acute Exacerbation of Interstitial Lung Disease After SARS-CoV-2 Vaccination: A Case Series.

Chest 2022 Dec;162;e311-e316 — 2022 Dec — e311-e316

Park JY, Kim JH, Park S, Hwang YI, Kim HI, Jang SH, Jung KS, Kim YK, Kim HA, Lee IJ

Clinical characteristics of patients with COVID-19 vaccine-related pneumonitis: a case series and literature review.

The Korean journal of internal medicine 2022 Aug 22;; — 2022 Aug 22

Bocchino M, Rea G, Buonocore A, Lieto R, Mazzocca A, Di Domenico A, Stanziola AA

Combination of acute exacerbation of idiopathic nonspecific interstitial pneumonia and pulmonary embolism after booster anti-COVID-19 vaccination.

Respiratory medicine case reports 2022;38;101674 — 2022 — 101674

Sgalla G, Magrì T, Lerede M, Comes A, Richeldi L

COVID-19 Vaccine in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis.

American journal of respiratory and critical care medicine 2022 Apr 12;; — 2022 Apr 12

Bando T, Takei R, Mutoh Y, Sasano H, Yamano Y, Yokoyama T, Matsuda T, Kataoka K, Kimura T, Kondoh Y

Acute Exacerbation of Idiopathic Pulmonary Fibrosis after SARS-CoV-2 Vaccination.

The European respiratory journal 2022 Feb 10;; — 2022 Feb 10

Ghincea A, Ryu C, Herzog EL

An Acute Exacerbation of Idiopathic Pulmonary Fibrosis After BNT162b2 mRNA COVID-19 Vaccination: A Case Report.

Chest 2022 02;161;e71-e73 — 2022 02 — e71-e73